Working… Menu
Trial record 1 of 8 for:    M281
Previous Study | Return to List | Next Study

An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03896295
Recruitment Status : Terminated (Study was originally halted due to the COVID-19 pandemic. The study was later terminated prematurely as the participants will have the option to enter into an open-label extension portion of a planned future study. It was not due to safety concerns.)
First Posted : March 29, 2019
Last Update Posted : May 13, 2021
Information provided by (Responsible Party):
Momenta Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 9, 2020
Actual Study Completion Date : December 9, 2020